钙蛋白颗粒抑制解释镁介导的血管钙化保护作用
该研究探讨镁离子(Mg2+)对抗高磷和继发性结晶钙蛋白颗粒(CPP2)诱导的血管钙化的机制。体外实验显示Mg2+可预防高磷诱导的血管平滑肌细胞钙化,并剂量依赖性延迟CPP1向CPP2成熟;在人血清中,添加0.2 mmol/L Mg2+使健康对照T50增加51±15分钟(P<0.05),CKD患者增加44±13分钟(P<0.05),且进一步添加可进一步增加。结论表明结晶CPP2介导高磷诱导的血管钙化,Mg2+通过延迟CPP2形成而预防钙化。
要点
- 镁离子可预防高磷诱导的血管平滑肌细胞钙化。
- 镁离子剂量依赖性延迟CPP1向CPP2的体外成熟。
- 镁离子对已形成的CPP2无预防钙化作用。
核心结论
- 结晶CPP2介导高磷诱导的血管平滑肌细胞钙化。
- 镁离子通过延迟结晶CPP2形成而预防高磷诱导的钙化。
研究设计与样本
- 体外研究:血管平滑肌细胞分别接受高磷或CPP2处理并补充镁离子,观察细胞钙化。
- 通过培养基吸光度、电子显微镜和能量色散谱研究镁离子对CPP成熟、形态和组成的影响。
- 在人血清中测定镁离子对CKD患者和健康对照的钙化倾向(T50)的影响。
主要发现
- 镁离子补充预防高磷诱导的血管平滑肌细胞钙化。
- 镁离子剂量依赖性延迟体外原代CPP1向CPP2的成熟。
- 当加入已形成的CPP2时,镁离子未能预防钙化及相关基因和蛋白表达。
- 在人血清中,添加0.2 mmol/L镁离子使健康对照T50增加51±15分钟(P<0.05),CKD患者增加44±13分钟(P<0.05)。
- 每进一步添加0.2 mmol/L镁离子均导致两组T50进一步增加。
关键数值与推荐
- 在人血清中,添加0.2 mmol/L镁离子使健康对照T50增加51±15分钟(P<0.05)。
- 在人血清中,添加0.2 mmol/L镁离子使CKD患者T50增加44±13分钟(P<0.05)。
临床怎么用
- 镁离子可能通过抑制钙蛋白颗粒成熟来降低血管钙化风险。
- 血清T50测定可用于评估镁离子对钙化倾向的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Phosphate (Pi) toxicity is a strong determinant of vascular calcification development in chronic kidney disease (CKD). Magnesium (Mg2+) may improve cardiovascular risk via vascular calcification. The mechanism by which Mg2+ counteracts vascular calcification remains incompletely described. Here we investigated the effects of Mg2+ on Pi and secondary crystalline calciprotein particles (CPP2)-induced calcification and crystal maturation. METHODS: Vascular smooth muscle cells (VSMCs) were treated with high Pi or CPP2 and supplemented with Mg2+ to study cellular calcification. The effect of Mg2+ on CPP maturation, morphology and composition was studied by medium absorbance, electron microscopy and energy dispersive spectroscopy. To translate our findings to CKD patients, the effects of Mg2+ on calcification propensity (T50) were measured in sera from CKD patients and healthy controls. RESULTS: Mg2+ supplementation prevented Pi-induced calcification in VSMCs. Mg2+ dose-dependently delayed the maturation of primary CPP1 to CPP2 in vitro. Mg2+ did not prevent calcification and associated gene and protein expression when added to already formed CPP2. Confirmatory experiments in human serum demonstrated that the addition of 0.2 mmol/L Mg2+ increased T50 from healthy controls by 51 ± 15 min (P < 0.05) and CKD patients by 44 ± 13 min (P < 0.05). Each further 0.2 mmol/L addition of Mg2+ led to further increases in both groups. CONCLUSIONS: Our results demonstrate that crystalline CPP2 mediates Pi-induced calcification in VSMCs. In vitro, Mg2+ delays crystalline CPP2 formation and thereby prevents Pi-induced calcification.
引用
- Ter Braake AD, Eelderink C, Zeper LW, et al. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Nephrol Dial Transplant. 2020. PMID: 31605492. doi:10.1093/ndt/gfz190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。